Background: Novel approaches in the diagnostics of T. gondii have enabled a detection of the parasite in the amniotic fl uid or blood of pregnant women. Objective: The high titres of IgM and IgG antibodies against T. gondii are not always indicative of the presence of this parasite in pregnant women, therefore the molecular assays can be used to diagnose and genetically characterise T. gondii in amniotic fl uids and blood samples. Methods: The study analysed 15 samples of amniotic fl uid and 1 sample of the blood from pregnant women suspected for toxoplasmosis. The serological ELISA test was used for the immunological study and molecular analyses, PCR at SAG2 locus followed by RFLP analysis were used for Toxoplasma gondii genotyping. Conclusion: Using PCR assay with TGR1E gene we have confi rmed the presence of T. gondii in the blood of a pregnant woman. The parasite was typed as genotype I, belonging to virulent strains (Tab. 1, Fig. 2 
Toxoplasmosis is one of the most common parasitic infections with a worldwide prevalence. Though causing an asymptomatic infection in a healthy host (80 -90 %), it can be accompanied by non-specifi c clinical symptoms (swollen lymph nodes in the neck area, fewer, head and muscle aches, increased fatigue). Rarely, an immunocompetent individual may develop distinct symptoms, e.g. generalised lymphadenopathy, maculo-papular exanthema, hepatitis, encephalitis, myocarditis, however, in very rare cases, the infection can be fatal (1, 2) . The incubation period for toxoplasmosis is usually 4 -21 days (with an average of 7 days) (3) . Clinical manifestation of T. gondii infection depends on the hostparasite interaction, virulence, infective dose, host immunocompetence and age (4) .
Toxoplasmosis present a serious health threat to immunocompromised patients and pregnant women that were infected for the fi rst time immediately prior to or during pregnancy.
Toxoplasmosis is a common opportunistic infection in immunosupressed individuals, in particular AIDS patients (5, 6, 7), organ transplant recipients (8) and in patients with malignant diseases (9) . Bradyzoites-to-tachyzoites conversion in AIDS patients results in encephalitis (10) with the prevalence of 25 % (11) and also in pneumonia and chorioretinitis. T. gondii infection can be activated by cysts after an organ transplant, or by tachyzoites transmitted through blood transfusion. Immunosuppressed patients are at a risk for reactivation of latent toxoplasmosis (12) . Negative pregnant women are especially at risk for a vertical transmission to foetus. In such cases, T. gondii infection could induce a life-threatening disease in foetus (13) .
Encysted bradyzoites that persist in the tissue cysts, localized in the CNS, heart and skeletal muscles are distinctive for latent toxoplasmosis (14) . They induce immune response that persists throughout the lifetime of the host (8) . Bradyzoites in the tissue cysts are a source of infection when transmitted to humans from domestic animals. In immunodefi cient individuals, the release of bradyzoites and subsequent transformation to tachyzoites may result in fatal Toxoplasma encephalitis (15, 9, 16) .
The aim of the study was to detect T. gondii in the blood and amniotic fl uid samples of pregnant women and genetically characterise the causative agent of toxoplasmosis.
Material and methods
In co-operation with several medical facilities (Louis Pasteur University Hospital, Kosice) a total of 16 samples of amniotic fl uid and blood of pregnant women were collected. ELISA tests confi rmed high titres of IgG and IgM antibodies specifi c to T. gondii. Isolated DNA of T. gondii was stored at -20 °C until further use.
ELISA test was used for a serological detection of the specifi c antibodies in sera (IgG, IgM) in the stage of an acute infection. The serological diagnosis is not that reliable in the case of toxo-plasmosis, the presence of T. gondii can be directly confi rmed only by using molecular methods, based on the DNA of parasite.
Amniotic fl uid (5 ml) was centrifuged at 95 -210 x g (Jouan BR4i, France) for 10 minutes at a standard laboratory temperature. For T. gondii isolation, sediment was diluted with 200 μl PBS (phosphate buffer) and used for the DNA isolation (2) .
Blood sample of a pregnant woman was collected into an EDTA tube and incubated in a water bath for 30 minutes at 37 °C. The phase, containing plasma, proteins and leucocytes was removed to 1.5 ml tube and centrifuged at 94 x g for 10 minutes. For DNA isolation, sediment containing leucocytes and T. gondi was used.
Commercial Kit QIAamp® DNA Mini Kit (QIAGEN, GmbH.,Hilden, Germany) was used to isolate T. gondii DNA from amniotic fl uid and blood. The DNA was isolated according to the manufacturer's protocol, using proteinase K digestion. The fi nal DNA volume was diluted in150 μl of water (Water, nuclease-free, Fermentas) and stored at -20 °C until further use.
The isolated DNA were analysed by PCR method with two primers of TGR1E gene according to Lamoril (17) and Čermáková (2). Amplifi cation was performed in 5 μl of the isolated DNA template. The positive fragment after amplifi cation consisted from 191 bp electrophoresed on a 3 % agarose gel stained with GoldView TM (SBS Genetech, China) and visualized under UV light at 254 nm.
Genotyping of DNA samples of T. gondii were performed using the nested PCR at SAG2 locus according to Howe (18) , located at chromosome VIII and the coding surface antigen P22. Samples were analyzed separately at the 5' and 3' regions of the locus, two set of primers were used in two amplifi cations.
For the RFLP analysis, the fragments after second amplifi cation at the SAG2 locus, 5´end 241 bp fragment and 3´-end 221 bp fragment were used. The amplifi ed fragments were digested with the restriction endonuclesaes Sau3A I (Promega, USA) at 5´ end and Hha I (Promega, USA) at 3´ end of locus. The samples were incubated for 3 hours at 37 °C according to Howe at al (1997) and reaction was fi nished by cooling to 10 °C. The position of the electrophoresed fragments at 5' and 3' ends visualized on 1.2 % gel determined the genotype of T. gondii.
Results
As there is a high risk for T. gondii tachyzoites transmission from an infected mother to foetus, causing foetal damage, our research has been focused on detecting T. gondii in the amniotic fl uid and blood of pregnant women.
A total of 15 amniotic fl uid samples, collected at several medical facilities and a single blood sample, collected into EDTA, were used for the T. gondii analyses. The ELISA tests were positive in all blood sera of pregnant women (IgG and IgM). Molecular diagnosis of T. gondii in amniotic fl uid samples was performed by the PCR method using TGR1E sequence. The presence of T. gondii was not confi rmed in any of the samples (Tab. 1).
T. gondii was detected only in the unclotted blood sample of a pregnant woman with high antibody titres. PCR assay using TGR1E sequence was positive and (Fig.1) and typing at the SAG2 locus revealed the presence of genotype I (Figs 1 and 2) , which is a virulent T. gondii strain.
Discussion
As pregnant women are the most vulnerable group when T. gondii infection is concerned, they have received the greatest at- tention in the study of toxoplasmosis. Primary infection during pregnancy may result in congenital toxoplasmosis, accompanied by severe damage to foetus or even miscarriage (16) . Toxoplasmosis, diagnosed in pregnant women, should be always treated, however, an early diagnosis is a key factor for the treatment effi cacy. More than 90 % of acute T. gondii infections are asymptomatic (19) , therefore determining primary infection solely on the basis of clinical signs during pregnancy is rather challenging. Ondriska (12) suggested that serological testing could be performed at the beginning of pregnancy, when the foetus is the most vulnerable and particularly prone to damage. For pregnant women with negative antibody titres, as frequent as in each term of the pregnancy, serology testing is advisable (20), as the infection may be acquired even during pregnancy. Studeničová (21) support the regular testing, as pregnant women lack the protection and are exposed to the T. gondii primary infection and potential congenital transmission to foetus.
T. gondii prevalence in human population has been associated with an exposure to risk factors, i.e. hand-to-mouth contact with contaminated soil, ingestion of raw or undercooked meat, contaminated vegetables, poor personal hygiene, unhygienic food processing (22) . 66 %, asymptomatic in 3.58 %, febrile form in 1.91 %, lung form in 13 cases, neonatal in 11 cases and dermatological and intestinal form in 7 cases. As much as 72.11 % of the patients recorded in their anamnesis a contact with animals, 3.91 % of the patients ingestion of raw meat, 2.16 % drinking raw milk and in 21.82 % of the patients the anamnesis were unknown. The infection occurred throughout the year, with the highest frequency in January and the lowest in December. The highest age-specifi c morbidity was found in the age group of 10-14 year old children (23) . It may be due to the fact such this age group come into regular and close contact with cats and dogs (24) .
In 2008, 175 new cases have been reported (morbidity of 3.24/ /100 000), out of which 62 were males (morbidity of 2.36) and 113 females (morbidity of 4.07). The infections have been reported from all regions in Slovakia, with the highest morbidity in the Trenčín region -9.84 (59 cases) and the lowest in the Bratislava region -0.82 (5 cases). The infections occurred throughout the whole year with the maximum in January (42 cases), were reported in all age groups and the highest age-specifi c morbidity was found in teenagers aged from 15 to 19 years (6.39). Following clinical forms of the infection have been detected: glandular form -123 cases, asymptomatic -31, ocular -9, unknown -5, gynaecological -4, intestinal -1, cardiac -1 and dermatological 1 case. Epidemiological anamneses in 119 cases stated a contact with domestic animals (contact with various domestic animals -44 cases, with a cat -35, with a dog and a cat -34, with a dog-6 cases), in 9 cases a contact with a cat and ingestion of undercooked meat and ingestion of raw goat milk, in one case ingestion of raw goat milk, in 8 cases contact with domestic animals, hand-to-mouth contact with soil in a playground, poor hygiene. In 35 cases, the epidemiological anamnesis was unknown (25).
An early and correct diagnosis is essential for the effi cient treatment. Positive or negative PCR result favours the decision -making regarding the specifi c therapy (26) . So far, no effi cient medication is available to eliminate tissue cysts as bradyzoites in cysts are protected against such medications by the tissue cysts membrane. Current therapy has therefore been focused on tachyzoites. The selected groups of patients with positive results receive sulfadiazine and pyrimethamine. If the results are negative, the spiramycine is recommended as a prevention (2) . A suitable human vaccine against T. gondii has not been developed yet (27) .
Using the molecular methods, T. gondii has been detected only in one blood sample of a seropositive pregnant woman. Serological examination of this sample confi rmed the presence of IgM and IgG antibodies. The patient's personal anamnesis revealed the fact that her pregnancy had been achieved through assisted reproduction, she had had close and frequent contact with domestic animals (cats, dogs, poultry, goats) and that she had suffered from headaches. T. gondii isolated from the blood samples was genetically characterised. This is the fi rst detection of T. gondii isolated from blood using molecular methods in Slovakia. The diagnosis of an acute toxoplasmosis was confi rmed, caused by genotype I.
Ho-Yen (28) suggested that the samples should be collected prior to antibiotic treatment, but not later that 2 to 3 days after the fi rst examination. Antibiotic treatment usually leads to a rapid elimination of the parasite and the DNA degradation, thus producing false negative PCR results (2) . These data correlate with our fi ndings resulting from examining all samples of amniotic fl uid, where the patients received antibiotic treatment immediately after detecting high T. gondii antibody titres.
Amniotic fl uid studies, preferably PCR amplifi cation of T. gondii DNA, are the best diagnostic tools for the detection of congenital toxoplasmosis during pregnancy (29) . PCR diagnosis from the amniotic fl uid largely depends on the gestational age, at which the mother acquired the infection. According to Romand (30) , the sensitivity of such prenatal diagnosis is signifi cantly higher if the mother acquired the infection between 17 and 21 weeks of gestation compared to infection acquired before the week 17 and after the week 21 of gestation (p<0.02). Romand (30) found, examining 270 amniotic fl uid samples, the PCR sensitivity of 64 % and specifi city of 100 %.
Conclusion
The serological diagnosis of toxoplasmosis has been known and utilized for a long time, however, implementing new molecular approaches (PCR assays), genotyping and determination of the causative agent virulence, facilitate an early and targeted treatment, thus preventing a damage to a foetus.
